3-D ultrasound upgrade enters market

Article

Biomedicom, a 1998 spin-off from Silicon Graphics, has begun shipping a 3-D ultrasound imaging platform called SonoReal. The product is compatible with existing 2-D ultrasound systems and features a positional sensor, which attaches to a 2-D transducer

Biomedicom, a 1998 spin-off from Silicon Graphics, has begun shipping a 3-D ultrasound imaging platform called SonoReal. The product is compatible with existing 2-D ultrasound systems and features a positional sensor, which attaches to a 2-D transducer using a simple clip-on device, enabling the physician or sonographer to acquire slices that can be reconstructed into 3-D volume. Proprietary software supports semiautomated image segmentation capability. By drawing a contour around a selected area, the SonoReal can define and surround a region or organ of interest, automatically removing obscuring tissues. The product debuted earlier this year at the annual meetings of the American College of Obstetricians and Gynecologists and the American Institute of Ultrasound in Medicine.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.